A. Fernández-Ramírez , A. Olivas-Martinez , J. Ruiz-Manriquez , E. Kauffman-Ortega , C. Moctezuma-Velázquez , E. Marquez-Guillen , A.G. Contreras , M. Vilatobá , E. González-Flores , R. Cruz-Martínez , N.C. Flores-García , I. García-Juárez
{"title":"肝移植后的糖尿病和墨西哥队列糖尿病家族史的影响。","authors":"A. Fernández-Ramírez , A. Olivas-Martinez , J. Ruiz-Manriquez , E. Kauffman-Ortega , C. Moctezuma-Velázquez , E. Marquez-Guillen , A.G. Contreras , M. Vilatobá , E. González-Flores , R. Cruz-Martínez , N.C. Flores-García , I. García-Juárez","doi":"10.1016/j.rgmxen.2023.06.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction and aims</h3><p>Posttransplantation diabetes mellitus (PTDM) is a serious long-term complication that has a negative impact on graft and patient survival. The purpose of the present study was to describe the incidence of PTDM in a Mexican cohort and evaluate its association with a previous family history of diabetes (FHD).</p></div><div><h3>Methods</h3><p>A retrospective single-center cohort study was conducted on patients undergoing liver transplantation (LT). The primary outcome was time from LT to PTDM. The diagnosis of PTDM was established using the ADA criteria. A mediation analysis that used adjusted Cox regression models and considered pretransplant prediabetes a mediator was performed, to determine the total effect and direct effect of FHD on PTDM.</p></div><div><h3>Results</h3><p>A total of 152 patients were included, with a median follow-up time of 41 months; 19.2% (<em>n</em> = 29) had pretransplant diabetes. During the follow-up time, 15% of patients developed PTDM (<em>n</em> = 23), with an incidence rate of 4.71 cases/100 person-years. PTDM was significantly higher in patients with FHD, compared with those with no FHD (8.72 cases/100 person-years <em>vs</em> 2.04 cases/100 person-years, respectively; <em>p</em> = 0.001). The adjusted hazard ratio of PTDM for FHD was 4.14 (95% CI 1.60–10.7), <em>p</em> = 0.005) and 3.48 (95% CI 1.35–9.01, <em>p</em> = 0.010), when further controlled for pretransplant prediabetes.</p></div><div><h3>Conclusion</h3><p>The occurrence of PTDM was similar to that reported in most international studies. As with type 2 diabetes, family history plays an important role in the development of PTDM, even after accounting for pretransplant prediabetes. Patients with FHD should undergo a stricter metabolic program.</p></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"89 2","pages":"Pages 249-257"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2255534X23001123/pdfft?md5=356adefe7b0887fcfee1e70c081dbc75&pid=1-s2.0-S2255534X23001123-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Posttransplantation diabetes mellitus after liver transplant and the impact of family history of diabetes in a Mexican cohort\",\"authors\":\"A. Fernández-Ramírez , A. Olivas-Martinez , J. Ruiz-Manriquez , E. Kauffman-Ortega , C. Moctezuma-Velázquez , E. Marquez-Guillen , A.G. Contreras , M. Vilatobá , E. González-Flores , R. Cruz-Martínez , N.C. Flores-García , I. García-Juárez\",\"doi\":\"10.1016/j.rgmxen.2023.06.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction and aims</h3><p>Posttransplantation diabetes mellitus (PTDM) is a serious long-term complication that has a negative impact on graft and patient survival. The purpose of the present study was to describe the incidence of PTDM in a Mexican cohort and evaluate its association with a previous family history of diabetes (FHD).</p></div><div><h3>Methods</h3><p>A retrospective single-center cohort study was conducted on patients undergoing liver transplantation (LT). The primary outcome was time from LT to PTDM. The diagnosis of PTDM was established using the ADA criteria. A mediation analysis that used adjusted Cox regression models and considered pretransplant prediabetes a mediator was performed, to determine the total effect and direct effect of FHD on PTDM.</p></div><div><h3>Results</h3><p>A total of 152 patients were included, with a median follow-up time of 41 months; 19.2% (<em>n</em> = 29) had pretransplant diabetes. During the follow-up time, 15% of patients developed PTDM (<em>n</em> = 23), with an incidence rate of 4.71 cases/100 person-years. PTDM was significantly higher in patients with FHD, compared with those with no FHD (8.72 cases/100 person-years <em>vs</em> 2.04 cases/100 person-years, respectively; <em>p</em> = 0.001). The adjusted hazard ratio of PTDM for FHD was 4.14 (95% CI 1.60–10.7), <em>p</em> = 0.005) and 3.48 (95% CI 1.35–9.01, <em>p</em> = 0.010), when further controlled for pretransplant prediabetes.</p></div><div><h3>Conclusion</h3><p>The occurrence of PTDM was similar to that reported in most international studies. As with type 2 diabetes, family history plays an important role in the development of PTDM, even after accounting for pretransplant prediabetes. Patients with FHD should undergo a stricter metabolic program.</p></div>\",\"PeriodicalId\":74705,\"journal\":{\"name\":\"Revista de gastroenterologia de Mexico (English)\",\"volume\":\"89 2\",\"pages\":\"Pages 249-257\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2255534X23001123/pdfft?md5=356adefe7b0887fcfee1e70c081dbc75&pid=1-s2.0-S2255534X23001123-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista de gastroenterologia de Mexico (English)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2255534X23001123\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de gastroenterologia de Mexico (English)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2255534X23001123","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Posttransplantation diabetes mellitus after liver transplant and the impact of family history of diabetes in a Mexican cohort
Introduction and aims
Posttransplantation diabetes mellitus (PTDM) is a serious long-term complication that has a negative impact on graft and patient survival. The purpose of the present study was to describe the incidence of PTDM in a Mexican cohort and evaluate its association with a previous family history of diabetes (FHD).
Methods
A retrospective single-center cohort study was conducted on patients undergoing liver transplantation (LT). The primary outcome was time from LT to PTDM. The diagnosis of PTDM was established using the ADA criteria. A mediation analysis that used adjusted Cox regression models and considered pretransplant prediabetes a mediator was performed, to determine the total effect and direct effect of FHD on PTDM.
Results
A total of 152 patients were included, with a median follow-up time of 41 months; 19.2% (n = 29) had pretransplant diabetes. During the follow-up time, 15% of patients developed PTDM (n = 23), with an incidence rate of 4.71 cases/100 person-years. PTDM was significantly higher in patients with FHD, compared with those with no FHD (8.72 cases/100 person-years vs 2.04 cases/100 person-years, respectively; p = 0.001). The adjusted hazard ratio of PTDM for FHD was 4.14 (95% CI 1.60–10.7), p = 0.005) and 3.48 (95% CI 1.35–9.01, p = 0.010), when further controlled for pretransplant prediabetes.
Conclusion
The occurrence of PTDM was similar to that reported in most international studies. As with type 2 diabetes, family history plays an important role in the development of PTDM, even after accounting for pretransplant prediabetes. Patients with FHD should undergo a stricter metabolic program.